| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Jin David | Chief Financial Officer | C/O FORTRESS BIOTECH, INC., 1111 KANE CONCOURSE SUITE 301, BAY HARBOR ISLANDS | /s/ David Jin | 02 Oct 2025 | 0001930732 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FBIO | Common Stock, par value $0.001 | Award | $3,549 | +2,711 | +0.22% | $1.31 | 1,248,604 | 01 Oct 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| F2 | Total holdings include 1,230,000 shares underlying deferred restricted stock units. |